Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

AI-driven medical imaging may help fight against rectal cancer

Building on its successes in applying artificial intelligence (AI) to medical imaging to enhance treatment of other diseases, a Case Western Reserve University-led team next will test its approach with rectal cancer patients.

4 Dec 2021

Modulating the composition of bacterial populations in the colon could enhance anti-tumor immunity

A bacterium common in the mouse gut microbiome can charge up the immune system to fight cancer cells in the colon, researchers from the University of Pittsburgh School of Medicine report today in the journal Immunity.

3 Dec 2021

New NCCN patient guideline explains when and how to screen for colorectal cancer

The National Comprehensive Cancer Network today announced the publication of new NCCN Guidelines for Patients: Colorectal Cancer Screening.

1 Dec 2021

Novel anti-inflammatory drug target identified by CRISPR

In this interview, News-Medical speaks to Dr. Jeffrey Rathmell about his recent research into how metabolic pathways impact immune function.

1 Dec 2021

Study finds under-representation of certain populations in cancer clinical trials

In a study examining disparities and trends in the inclusion of minorities, women, and older patients in cancer clinical trials, investigators found that certain populations remain under-represented.

25 Nov 2021

Lef1 gene restricts formation of cancer stem cell niches to suppress colorectal tumor growth

The new research findings help to understand mechanisms that lead to different types of intestinal tumors. They show that the Lef1 gene suppresses the development and growth of colorectal cancer by restricting the formation of cancer stem cell niches.

18 Nov 2021

Potential therapeutic targets of hydrogen for treatment of the COVID-19

A recent article provided a review of a study led by academician Zhong Nanshan, in China, on COVID-19 treatment by inhalation of a mixed gas composed of hydrogen and oxygen.

12 Nov 2021

Washington University School of Medicine receives $17 million to address disparities in cancers

Washington University School of Medicine in St. Louis has received a $17 million grant from the National Institutes of Health to address disparities in cancer research, treatment and outcomes in underrepresented populations.

6 Nov 2021

Brooklyn College announces the launch of BCCC-CURE to enhance the lives of cancer patients

Cancer is the second leading cause of death in New York State after heart disease among adults and the second cause of death among children after injuries. And the number of people diagnosed with the disease increases every year.

2 Nov 2021

The impacts of the SARS-CoV-2 pandemic on digestive health

The UEG Public Affairs Committee has published a position paper to educate policymakers, patients, healthcare professionals, and the general public about the impacts of the COVID-19 pandemic on digestive health.

2 Nov 2021

Drug-like molecule can counteract the effects of mutated epigenetic regulators that drive cancers

A decade ago, genome sequencing revealed a big surprise: about 50 percent of human cancers are linked to mutations in what are known as epigenetic regulators, which control the activity of genes.

29 Oct 2021

UAB researchers show how to identify non-responding tumors and improve immunotherapy response

Immunotherapy using checkpoint inhibitors can work well to treat cancer, but only a minority of patients respond to therapy.

28 Oct 2021

Study: Younger and older patients with metastatic colorectal cancer survive for same amount of time

Even though young patients with metastatic colorectal cancer tend to be more fit and receive more intensive treatment than older patients, both groups survive for roughly the same amount of time, according to a new study by Dana-Farber Cancer Institute investigators.

27 Oct 2021

Telemedicine approach remains a viable alternative for lung cancer screening

A novel telemedicine lung cancer screening effort during the COVID-19 pandemic shows that virtual single-visit screenings are just as effective as single-visit screenings done in person at the hospital, according to a study presented at the American College of Surgeons Virtual Clinical Congress 2021.

25 Oct 2021

Deep learning algorithm can accurately detect molecular pathways, key mutations in colorectal cancer

A new deep learning algorithm created by researchers from the University of Warwick can pick up the molecular pathways and development of key mutations causing colorectal cancer more accurately than existing methods, meaning patients could benefit from targeted therapies with quicker turnaround times and at a lower cost.

20 Oct 2021

Impact of BRCA1 mRNA expression on survival of patients breast and colorectal cancer

Oncotarget published "Opposing effects of BRCA1 mRNA expression on patient survival in breast and colorectal cancer and variations among African American, Asian, and younger patients" which reported that LMNB2 is a chromatin remodeling protein that also plays a role in eukaryotic cell proliferation by organizing the nuclear membrane during mitosis.

13 Oct 2021

Research provides insights on colorectal cancers’ immunotherapy resistance

Immune checkpoint inhibitors, which unleash the immune response against tumor cells, have revolutionized cancer treatment; however, the medications aren't effective in a large number of patients, including those with colorectal cancer.

11 Oct 2021

Novel peptide-drug conjugate enhances the efficacy of immunotherapy in preclinical cancer models

A peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint inhibitors in preclinical cancer models, according to results presented at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics, held October 7-10, 2021.

7 Oct 2021

NRG Oncology launches highly anticipated colorectal cancer prevention study

Today, NRG Oncology activated the highly anticipated colorectal cancer prevention trial, FORTE, NRG-CC005. FORTE (Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps) is a large, randomized trial of surveillance colonoscopy for participants with a first-time diagnosis of 1 or 2 small benign polyps, called adenomas.

6 Oct 2021

Novel scoring tools developed for predicting risk of colon cancer and precancerous polyps

Researchers have created novel scoring tools for predicting actual risk of colon cancer and advanced precancerous polyps for patients at average for the disease.

5 Oct 2021

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

AI-driven medical imaging may help fight against rectal cancer

Modulating the composition of bacterial populations in the colon could enhance anti-tumor immunity

New NCCN patient guideline explains when and how to screen for colorectal cancer

Novel anti-inflammatory drug target identified by CRISPR

Study finds under-representation of certain populations in cancer clinical trials

Lef1 gene restricts formation of cancer stem cell niches to suppress colorectal tumor growth

Potential therapeutic targets of hydrogen for treatment of the COVID-19

Washington University School of Medicine receives $17 million to address disparities in cancers

Brooklyn College announces the launch of BCCC-CURE to enhance the lives of cancer patients

The impacts of the SARS-CoV-2 pandemic on digestive health

Drug-like molecule can counteract the effects of mutated epigenetic regulators that drive cancers

UAB researchers show how to identify non-responding tumors and improve immunotherapy response

Study: Younger and older patients with metastatic colorectal cancer survive for same amount of time

Telemedicine approach remains a viable alternative for lung cancer screening

Deep learning algorithm can accurately detect molecular pathways, key mutations in colorectal cancer

Impact of BRCA1 mRNA expression on survival of patients breast and colorectal cancer

Research provides insights on colorectal cancers’ immunotherapy resistance

Novel peptide-drug conjugate enhances the efficacy of immunotherapy in preclinical cancer models

NRG Oncology launches highly anticipated colorectal cancer prevention study

Novel scoring tools developed for predicting risk of colon cancer and precancerous polyps

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in